Document DGx0ga4NNKXxE1EBLD9q31e8B

2965254 Kindeva DRUG DELIVERY 5.1.2e M: 5 1.2e 1O: 5.1.2e www.kindevadd.com I liMprommmal Fp!' %w ay Unkatin Profile Updated contact information coming soon! From: 5.1 2c <MMEMIlexponent.com> Sent: 12 November 2020 14:45 To: 5.1.2e <MEW MMM COM> Cc: MMI:=Kglar SMik; 51 2e <ME= nn M M . CO M>; <MEM.i iim.com> Subject: [EXTERNAL] RE: Update on PFAS: Request for Information Issued 5.1.2e Dear 5 1 2e Thank you very much for reaching out on this important topic. As you correctly understand, Exponent is working on PEAS projects related to fluorinated gases and food. However, pharmaceutical aerosols are outside the scope of our projects and instead fall into a project concerned with the use of PFAS in medical devices and pharmaceuticals that is being led by De Milieutafel. The contact person there is gm 5.1.2e 5.1.2e I)demilieutafel.nl. We are separately in contact with your colleagues 5 1 2e and 5 1 2e (in copy) in relation to our projects. I hope that helps and good luck! Best regards 5.1.2e 5.1.2e Exponent International Limited 1 Pride Point Drive Pride park, Derby DE24 8BX Direct Mobile 5.1.2e Email: Migexponent.com www.exponent.com CONFIDENTIALITY NOTICE: This e-mail transmission (and the attachments accompanying it) is intended only for the use of the intended recipient and may contain confidential information belonging to the sender. If you are not the intended recipient, be aware that any disclosure, copying, dissemination, distribution or use of the